Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

A Non-interventional Clinical Trial Assessing Immune Responses After Radiofrequency Ablation of Liver Metastases From Colorectal Cancer.

Löffler MW, Nussbaum B, Jäger G, Jurmeister PS, Budczies J, Pereira PL, Clasen S, Kowalewski DJ, Mühlenbruch L, Königsrainer I, Beckert S, Ladurner R, Wagner S, Bullinger F, Gross TH, Schroeder C, Sipos B, Königsrainer A, Stevanović S, Denkert C, Rammensee HG, Gouttefangeas C, Haen SP.

Front Immunol. 2019 Nov 19;10:2526. doi: 10.3389/fimmu.2019.02526. eCollection 2019.

2.

Next generation sequencing of lung adenocarcinoma subtypes with intestinal differentiation reveals distinct molecular signatures associated with histomorphology and therapeutic options.

Jurmeister P, Vollbrecht C, Behnke A, Frost N, Arnold A, Treue D, Rückert JC, Neudecker J, Schweizer L, Klauschen F, Horst D, Hummel M, Dietel M, von Laffert M.

Lung Cancer. 2019 Dec;138:43-51. doi: 10.1016/j.lungcan.2019.10.005. Epub 2019 Oct 11.

PMID:
31634654
3.

Machine learning analysis of DNA methylation profiles distinguishes primary lung squamous cell carcinomas from head and neck metastases.

Jurmeister P, Bockmayr M, Seegerer P, Bockmayr T, Treue D, Montavon G, Vollbrecht C, Arnold A, Teichmann D, Bressem K, Schüller U, von Laffert M, Müller KR, Capper D, Klauschen F.

Sci Transl Med. 2019 Sep 11;11(509). pii: eaaw8513. doi: 10.1126/scitranslmed.aaw8513.

PMID:
31511427
4.

Immunohistochemical analysis of Bcl-2, nuclear S100A4, MITF and Ki67 for risk stratification of early-stage melanoma - A combined IHC score for melanoma risk stratification.

Jurmeister P, Bockmayr M, Treese C, Stein U, Lenze D, Jöhrens K, Friedling F, Dietel M, Klauschen F, Marsch W, Fiedler E, von Laffert M.

J Dtsch Dermatol Ges. 2019 Aug;17(8):800-808. doi: 10.1111/ddg.13917.

PMID:
31437373
5.

Immunhistochemische Analyse von Bcl-2, nukleärem S100A4, MITF und Ki67 zur Risikostratifizierung von Melanomen im Frühstadium - ein kombinierter immunhistochemischer Score.

Jurmeister P, Bockmayr M, Treese C, Stein U, Lenze D, Jöhrens K, Friedling F, Dietel M, Klauschen F, Marsch W, Fiedler E, von Laffert M.

J Dtsch Dermatol Ges. 2019 Aug;17(8):800-809. doi: 10.1111/ddg.13917_g. German.

PMID:
31437365
6.

Use of quantitative T2 mapping for the assessment of renal cell carcinomas: first results.

Adams LC, Bressem KK, Jurmeister P, Fahlenkamp UL, Ralla B, Engel G, Hamm B, Busch J, Makowski MR.

Cancer Imaging. 2019 Jun 7;19(1):35. doi: 10.1186/s40644-019-0222-8.

7.

Assessment of the extracellular volume fraction for the grading of clear cell renal cell carcinoma: first results and histopathological findings.

Adams LC, Jurmeister P, Ralla B, Bressem KK, Fahlenkamp UL, Engel G, Siepmann S, Wagner M, Hamm B, Busch J, Makowski MR.

Eur Radiol. 2019 Nov;29(11):5832-5843. doi: 10.1007/s00330-019-06087-x. Epub 2019 Mar 18.

PMID:
30887194
8.

DNA methylation profiling reliably distinguishes pulmonary enteric adenocarcinoma from metastatic colorectal cancer.

Jurmeister P, Schöler A, Arnold A, Klauschen F, Lenze D, Hummel M, Schweizer L, Bläker H, Pfitzner BM, Mamlouk S, Sers C, Denkert C, Stichel D, Frost N, Horst D, von Laffert M, Capper D.

Mod Pathol. 2019 Jun;32(6):855-865. doi: 10.1038/s41379-019-0207-y. Epub 2019 Feb 5.

PMID:
30723296
9.

RNA-based analysis of ALK fusions in non-small cell lung cancer cases showing IHC/FISH discordance.

Vollbrecht C, Lenze D, Hummel M, Lehmann A, Moebs M, Frost N, Jurmeister P, Schweizer L, Kellner U, Dietel M, von Laffert M.

BMC Cancer. 2018 Nov 22;18(1):1158. doi: 10.1186/s12885-018-5070-6.

10.

Prognostic significance of Ki-67 levels and hormone receptor expression in low-grade serous ovarian carcinoma: an investigation of the Tumor Bank Ovarian Cancer Network.

Sehouli J, Braicu EI, Richter R, Denkert C, Jank P, Jurmeister PS, Kunze CA, Budczies J, Darb-Esfahani S, Schmitt WD, Traut A, Grabowski J, Taube ET, Plett H.

Hum Pathol. 2019 Mar;85:299-308. doi: 10.1016/j.humpath.2018.10.020. Epub 2018 Nov 11.

PMID:
30428389
11.

Native T1 Mapping as an In Vivo Biomarker for the Identification of Higher-Grade Renal Cell Carcinoma: Correlation With Histopathological Findings.

Adams LC, Ralla B, Jurmeister P, Bressem KK, Fahlenkamp UL, Hamm B, Busch J, Makowski MR.

Invest Radiol. 2019 Feb;54(2):118-128. doi: 10.1097/RLI.0000000000000515.

PMID:
30379727
12.

[Early diagnosis and localization of cancer by liquid biopsy].

Jurmeister P.

Pathologe. 2018 Jul;39(4):328-329. doi: 10.1007/s00292-018-0454-6. German. No abstract available.

PMID:
29951738
13.

Two patients with rare mixed adenoneuroendocrine carcinomas of the rectum.

Gül-Klein S, Sinn M, Jurmeister PS, Biebl M, Weiß S, Rau B, Bläker H, Pratschke J, Aigner F.

SAGE Open Med Case Rep. 2018 Mar 14;6:2050313X18758816. doi: 10.1177/2050313X18758816. eCollection 2018.

14.

ALK-FISH borderline cases in non-small cell lung cancer: Implications for diagnostics and clinical decision making.

von Laffert M, Stenzinger A, Hummel M, Weichert W, Lenze D, Warth A, Penzel R, Herbst H, Kellner U, Jurmeister P, Schirmacher P, Dietel M, Klauschen F.

Lung Cancer. 2015 Dec;90(3):465-71. doi: 10.1016/j.lungcan.2015.09.022. Epub 2015 Oct 23.

PMID:
26547803
15.

Parallel screening for ALK, MET and ROS1 alterations in non-small cell lung cancer with implications for daily routine testing.

Jurmeister P, Lenze D, Berg E, Mende S, Schäper F, Kellner U, Herbst H, Sers C, Budczies J, Dietel M, Hummel M, von Laffert M.

Lung Cancer. 2015 Feb;87(2):122-9. doi: 10.1016/j.lungcan.2014.11.018. Epub 2014 Dec 6.

PMID:
25534130

Supplemental Content

Loading ...
Support Center